Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

✍ Scribed by V. Schirrmacher; K. Bosslet; G. Shantz; K. Clauer; D. Hijbsch

• Publisher: John Wiley and Sons
• Year: 1979
• Tongue: French
• Weight: 797 KB
• Volume: 23
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.2910230216

✦ Synopsis

Abstract

The syngeneic cytotoxic T‐cell response against a metastasizing murine lymphoma variant was investigated and compared with the response against the non‐metastasizing parental tumor line Eb. Anti‐tumor cytotoxicity was not detectable in a 4‐h ^51^Cr release assay in spleens taken directly from tumor‐bearing animals (primary CMC). After restimulation in vitro (secondary CMC) however, high anti‐tumor cytotoxic activity was detected. This activity was mediated by immune T lymphocytes as shown by its sensitivity to treatment with anti‐Thy 1.2 serum and complement. Ten cells of the metastasizing tumor ESb, inoculated subcutaneously, were sufficient to raise a local tumor and metastases and to induce cytotoxic T memory cells in the spleens. In contrast, about 10^4^ cells were required to raise a local tumor and to induce splenic cytotoxic T memory cells, when the parental tumor Eb was tested. The specificity studies of the anti‐tumor cytotoxic activity demonstrated that cytotoxic T cells could distinguish unrelated, chemically induced syngeneic tumors and also recognize antigenic differences between the parental tumor Eb and its variant ESb. Eb and ESb tumor cells were recognized as carrying distinct antigens at the responder cell level, the stimulator cell level and the target cell level. The in vivo significance of these findings is discussed.